Previous 10 | Next 10 |
home / stock / nvzmf / nvzmf news
The following slide deck was published by Novozymes A/S in conjunction with their 2022 Q4 earnings call. For further details see: Novozymes A/S 2022 Q4 - Results - Earnings Call Presentation
Novozymes A/S press release ( OTCPK:NVZMF ): Q4 GAAP EPS of DKK3.18. Revenue of DKK4.53B (+19.2% Y/Y). For further details see: Novozymes A/S GAAP EPS of DKK3.18, revenue of DKK4.53B
Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more than a decade, and Novozymes is confident about the 2023 outlook of 4-7%. COPENHAGEN, Denmark – January 26, ...
Summary Novozymes is a Danish company that produces industrial enzymes, often used to replace chemicals in products and industrial processes. The company's products have a wide range of applications in household care, food and beverage, bio-energy, agriculture, feed, and even pharmaceut...
Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further...
Novozymes A/S (NVZMF) Q3 2022 Earnings Conference Call November 03, 2022 04:00 AM ET Company Participants Tobias Cornelius Bjorklund - Head-Investor Relations Ester Baiget - Chief Executive Officer Lars Green - Chief Financial Officer Tina Fanoe - Executive V...
The following slide deck was published by Novozymes A/S in conjunction with their 2022 Q3 earnings call. For further details see: Novozymes A/S 2022 Q3 - Results - Earnings Call Presentation
Novozymes A/S press release ( OTCPK:NVZMF ): Q3 Revenue of DKK4.37B (+16.2% Y/Y), (6% organic, 9% currency, 1% M&A). Novozymes increases its full-year organic sales growth outlook from previously 6-8% to now 8-9%. The full year organic sales growth indication for ...
Summary The passing of the Queen has swiftly circled the globe. Now, King Charles holds the torch and has significant power over economies, especially if more hands on than his mother. Interestingly, an initiative already lays out some of the King's favorite holdings and offer...
The following slide deck was published by Novozymes A/S in conjunction with their 2022 Q1 earnings call. For further details see: Novozymes A/S 2022 Q1 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Novozymes A/S Company Name:
NVZMF Stock Symbol:
OTCMKTS Market:
After the first quarter of 2023, Novozymes delivers stronger results than expected with 5% organic sales growth. The company confirms the 2023 outlook of 4-7% which is expected to be driven by pricing and volume growth. COPENHAGEN, Denmark – April 26, 2023. In the first three mon...
Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more than a decade, and Novozymes is confident about the 2023 outlook of 4-7%. COPENHAGEN, Denmark – January 26, ...
New York City, NY: May 25, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Enzyme Market in Global Industry: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and information relate...